Evanson Asset Management, LLC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 72 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2017. The put-call ratio across all filers is 2.77 and the average weighting 0.3%.

Quarter-by-quarter ownership
Evanson Asset Management, LLC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2019$109,000
+12.4%
20,0000.0%0.02%
+5.0%
Q3 2019$97,000
-32.6%
20,000
-3.8%
0.02%
-31.0%
Q2 2019$144,000
+2.1%
20,780
+2.4%
0.03%0.0%
Q1 2019$141,000
+18.5%
20,3000.0%0.03%
+7.4%
Q4 2018$119,000
-22.2%
20,3000.0%0.03%
-12.9%
Q3 2018$153,000
+48.5%
20,3000.0%0.03%
+55.0%
Q2 2018$103,000
-16.9%
20,3000.0%0.02%
-23.1%
Q1 2018$124,000
-13.9%
20,3000.0%0.03%
-10.3%
Q4 2017$144,000
-0.7%
20,3000.0%0.03%
-6.5%
Q3 2017$145,000
+11.5%
20,300
-1.7%
0.03%
+3.3%
Q2 2017$130,000
-22.6%
20,660
+1.5%
0.03%
-26.8%
Q1 2017$168,000
-0.6%
20,360
+1.8%
0.04%
-12.8%
Q4 2016$169,000
+24.3%
20,0000.0%0.05%
+20.5%
Q3 2016$136,000
+126.7%
20,0000.0%0.04%
+116.7%
Q2 2016$60,000
+233.3%
20,000
+100.0%
0.02%
+200.0%
Q1 2016$18,000
+5.9%
10,0000.0%0.01%0.0%
Q4 2015$17,000
+6.2%
10,0000.0%0.01%0.0%
Q3 2015$16,00010,0000.01%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2017
NameSharesValueWeighting ↓
Ikarian Capital, LLC 397,168$43,8880.01%
CJM Wealth Advisers, Ltd. 30,465$3,3660.00%
Tekla Capital Management LLC 154,310$17,0510.00%
McAdam, LLC 10,006$60.00%
Aries Wealth Management 15,400$1,7020.00%
WELLS FARGO & COMPANY/MN 342,084$37,8000.00%
JPMORGAN CHASE & CO 43,415$50.00%
NORTHERN TRUST CORP 207,329$22,9100.00%
PINNACLE ASSOCIATES LTD 18,580$2,0530.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders